arrow
F

François Potus

Laval University
H指数:38
被引数:4,480

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Germline and somatic variants in DNMT3A and other clonal haematopoiesis of indeterminate potential genes contribute to pulmonary arterial hypertension

DNMT3A基因及其他克隆性意义未明造血基因的生殖系和体细胞变异可导致肺动脉高压。

2025-08-011
OAAI
Unraveling AURKB as a potential therapeutic target in pulmonary hypertension using integrated transcriptomic analysis and pre-clinical studies

通过整合转录组学分析和临床前研究,阐明AURKB作为肺动脉高压潜在治疗靶点的价值。

2025-02-010
OAAI
ATP citrate lyase drives vascular remodeling in systemic and pulmonary vascular diseases through metabolic and epigenetic changes
2024-12-110
PRE
Integrin α5β1 represents a novel therapeutic target to improve vascular remodeling in pulmonary arterial hypertension

整合素α5β1是改善肺动脉高压血管重塑的一个新型治疗靶点。

2024-11-121
PRE
Integrin α5β1 contributes to pathological remodeling of the right ventricle in pulmonary arterial hypertension

整合素α5β1参与肺动脉高压中右心室病理性重塑。

2024-11-120
PRE
Targeting ATP Citrate Lyase: A Novel Therapeutic Strategy for Vascular Remodeling in Pulmonary Hypertension

靶向乙酰辅酶A柠檬酸合酶:肺动脉高压血管重塑的一种新型治疗策略

2024-11-120
PRE
Targeting Aurora Kinase B Improves Vascular Remodeling in Pulmonary Arterial Hypertension

靶向Aurora Kinase B改善肺动脉高压的血管重塑

2024-11-120
PRE
Treatment of pulmonary arterial hypertension by blocking integrin a5b1, a potential disease-modifying strategy

通过阻断整合素α5β1治疗肺动脉高压,一种潜在的改变疾病进程的策略

2024-11-120
PRE
Upregulation of Dynamin 2 (DNM2) Increases Mitochondrial Fission and Cell Proliferation in Pulmonary Arterial Hypertension

Dynamin 2 (DNM2)的上调增加肺动脉高压中的线粒体分裂和细胞增殖

2024-11-120
PRE
Aurora kinase B: A New Therapeutic Target in PAH
2024-10-300
PRE
Implication of Integrin α5β1 in right ventricular failure associated with pulmonary arterial hypertension
2024-10-300
PRE